![Karin Hansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karin Hansson
Amministratore Delegato presso
Scandibio Therapeutics AB
Profilo
Karin Marianne Hansson is the founder of Scandibio Therapeutics AB, founded in 2017, serving as Chief Executive Officer.
Dr. Hansson is the founder of Amylonix AB, founded in 2018, serving as Chief Executive Officer & Director.
Dr. Hansson is the founder of Scandiedge Therapeutics AB, founded in 2017, serving as Chief Executive Officer & Director.
Dr. Hansson is also the founder of Affibody AB,Protemedge AB,A05 Diagnostics AB..
Dr. Hansson is Chief Executive Officer & Director at Mariham Consulting AB. Dr. Hansson is Chief Executive Officer at Zytox Therapeutics AB. Former positions include Chief Executive Officer at Atlas Antibodies AB from 2006 to 2017, Independent Director at Q-linea AB from 2018 to 2023, Independent Director at Intervacc AB, Director at Atlas Therapeutics AB, Deputy Director at Antibodies Incentive AB, and Manager-Business Development at Affibody Medical AB. Education includes a graduate degree conferred in 1989 and a doctorate conferred in 1998, both from the Royal Institute of Technology.
Posizioni attive di Karin Hansson
| Società | Posizione | Inizio |
|---|---|---|
Scandibio Therapeutics AB
 Scandibio Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Provides science and technology research and development services | Amministratore Delegato | 01/11/2017 |
Amylonix AB
 Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Fondatore | 01/02/2018 |
Scandiedge Therapeutics AB | Fondatore | 01/11/2017 |
Mariham Consulting AB | Amministratore Delegato | - |
Protemedge AB | Fondatore | - |
A05 Diagnostics AB | Amministratore Delegato | - |
Precedenti posizioni note di Karin Hansson
| Società | Posizione | Fine |
|---|---|---|
| Q-LINEA AB | Direttore/Membro del Consiglio | 13/06/2023 |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Amministratore Delegato | 01/08/2017 |
Antibodies Incentive AB | Corporate Officer/Principal | - |
| ░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Karin Hansson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Q-linea AB
 Q-linea AB Medical SpecialtiesHealth Technology Develops procedures, instruments, and systems for protein and nucleic acid analysis | Health Technology |
Intervacc AB
 Intervacc AB BiotechnologyHealth Technology Develops and produces vaccines for the animal health sector | Health Technology |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Health Technology |
Antibodies Incentive AB | |
Scandibio Therapeutics AB
Scandibio Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Provides science and technology research and development services | Commercial Services |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Health Technology |
Scandiedge Therapeutics AB | |
Mariham Consulting AB | |
Protemedge AB | |
A05 Diagnostics AB |
